Chester County News and Community Website
WASHINGTON, D.C. — As part of the U.S. Department of Veterans Affairs (VA) fight against the COVID-19 pandemic, the department announced its nationwide effort to recruit volunteers for COVID-19 clinical …
Read More
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases, recently provided an update …
Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …
Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced financial results for the third quarter ended September 30, 2020.
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced its financial results for the third quarter of …
Read More
MALVERN, PA — Recro Pharma, Inc. (Nasdaq: REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both …
Read More MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced that, after a strategic review …
Read More
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) recently announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance.
Read More
The U.S. Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least …
Read More
The U.S. Food and Drug Administration recently announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over …
Read More